AdvaMed Welcomes Tarver as Head of CDRH

Washington, D.C. - AdvaMed, the Medtech Association, which represents more than 500 medical technology companies of all sizes as the largest global trade organization for medtech, released the following statements on the FDA's announcement that Dr. Michelle Tarver will serve as the permanent director of the Center for Devices and Radiological Health (CDRH):

Scott Whitaker, President and CEO, AdvaMed: "We're pleased by this news. Over her time as an ophthalmologist, epidemiologist, and medical device regulator, Dr. Tarver has made clear she understands the value of medical technology and the important role innovation plays in our health care system. We're confident she'll lead CDRH with a collaborative approach and an appreciation for the need to get safe, proven technologies into the hands of the patients and providers who need them."

Pete Arduini, President and CEO, GE HealthCare; Chair of the AdvaMed Board of Directors: "AdvaMed members look forward to working with Dr. Tarver and her team at CDRH as the FDA continues its work to improve patient care through its rigorous medical device review process. The FDA has an especially difficult task ahead as AI plays an increasingly critical role in health care. Ensuring the review process for these technologies is clear and consistent will be paramount. AdvaMed and industry stand ready to work with FDA to ensure safe and effective lifesaving technologies are brought to market."

# # #